Literature DB >> 16644236

Effects of estrogen variation on neural correlates of emotional response inhibition.

Zenab Amin1, C Neill Epperson, R Todd Constable, Turhan Canli.   

Abstract

Despite behavioral evidence that variation in ovarian hormones is associated with changes in affect, the neural basis of these processes is poorly understood. We combined functional magnetic resonance imaging (fMRI) with quantitative analysis of ovarian hormones in a within-subject design to investigate brain activation patterns during affective response inhibition, comparing activation between the early follicular (low estrogen and progesterone) and mid-luteal (high estrogen and progesterone) phases of the menstrual cycle in healthy women. There was significantly increased activation in the anterior cingulate and dorsolateral prefrontal cortex (DLPFC) while inhibiting response to positive words during the luteal, compared to the follicular phase. Furthermore, luteal phase estradiol level positively correlated with DLPFC activation while inhibiting response to positive words and negatively correlated with activation in several structures while inhibiting response to negative words, supporting estrogen's modulation of affective processing.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16644236     DOI: 10.1016/j.neuroimage.2006.03.013

Source DB:  PubMed          Journal:  Neuroimage        ISSN: 1053-8119            Impact factor:   6.556


  52 in total

1.  How reward and emotional stimuli induce different reactions across the menstrual cycle.

Authors:  Michiko Sakaki; Mara Mather
Journal:  Soc Personal Psychol Compass       Date:  2012-01-01

Review 2.  Sex hormones and pain: the evidence from functional imaging.

Authors:  Katy Vincent; Irene Tracey
Journal:  Curr Pain Headache Rep       Date:  2010-10

3.  Estrogen treatment impairs cognitive performance after psychosocial stress and monoamine depletion in postmenopausal women.

Authors:  Paul A Newhouse; Julie Dumas; Heather Wilkins; Emily Coderre; Cynthia K Sites; Magdalena Naylor; Chawki Benkelfat; Simon N Young
Journal:  Menopause       Date:  2010-07       Impact factor: 2.953

Review 4.  Sex differences and stress across the lifespan.

Authors:  Tracy L Bale; C Neill Epperson
Journal:  Nat Neurosci       Date:  2015-09-25       Impact factor: 24.884

Review 5.  Neuroimaging the Menstrual Cycle and Premenstrual Dysphoric Disorder.

Authors:  Erika Comasco; Inger Sundström-Poromaa
Journal:  Curr Psychiatry Rep       Date:  2015-10       Impact factor: 5.285

6.  Oral contraceptive pill use is associated with localized decreases in cortical thickness.

Authors:  Nicole Petersen; Alexandra Touroutoglou; Joseph M Andreano; Larry Cahill
Journal:  Hum Brain Mapp       Date:  2015-04-02       Impact factor: 5.038

7.  Brain responses to food images during the early and late follicular phase of the menstrual cycle in healthy young women: relation to fasting and feeding.

Authors:  Miguel Alonso-Alonso; Florencia Ziemke; Faidon Magkos; Fernando A Barrios; Mary Brinkoetter; Ingrid Boyd; Anne Rifkin-Graboi; Mary Yannakoulia; Rafael Rojas; Alvaro Pascual-Leone; Christos S Mantzoros
Journal:  Am J Clin Nutr       Date:  2011-05-18       Impact factor: 7.045

8.  The regulatory roles of progesterone and estradiol on emotion processing in women.

Authors:  Rupali Sharma; Andrew Cameron; Zhuo Fang; Nafissa Ismail; Andra Smith
Journal:  Cogn Affect Behav Neurosci       Date:  2021-05-13       Impact factor: 3.282

9.  GABAergic neuroactive steroids and resting-state functional connectivity in postpartum depression: a preliminary study.

Authors:  Kristina M Deligiannidis; Elif M Sikoglu; Scott A Shaffer; Blaise Frederick; Abby E Svenson; Andre Kopoyan; Chelsea A Kosma; Anthony J Rothschild; Constance M Moore
Journal:  J Psychiatr Res       Date:  2013-03-15       Impact factor: 4.791

Review 10.  Medical and psychological risks and consequences of long-term opioid therapy in women.

Authors:  Beth D Darnall; Brett R Stacey; Roger Chou
Journal:  Pain Med       Date:  2012-08-20       Impact factor: 3.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.